Company research
Strata Critical Medical, Inc.
CIK 1779128Updated Nov 15, 2026
SRTA price & chart
Loading TradingView…
NASDAQ:SRTA on TradingView ↗About the company
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery. Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
In the news
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13D - filed by Third Point LLC regarding Strata Critical Medical, Inc.
144 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 335,078,000Source | 282,945,000Source | 332,698,000Source | 257,919,000Source | 280,331,000Source | 327,618,000Source | 250,550,000Source | 282,792,000Source | 325,472,000Source | 256,675,000Source | 294,938,000Source | 325,025,000Source |
| Property, Plant and Equipment, NetUSD | 38,561,000Source | 30,550,000Source | 40,704,000Source | 33,697,000Source | 22,093,000Source | 40,087,000Source | 32,568,000Source | 3,468,000Source | 36,444,000Source | 30,918,000Source | 2,899,000Source | 2,037,000Source |
| GoodwillUSD | 84,607,000Source | 42,952,000Source | 106,946,000Source | 44,251,000Source | 39,574,000Source | 88,589,000Source | 42,038,000Source | 39,777,000Source | 88,210,000Source | 41,050,000Source | 40,373,000Source | 39,445,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 49,754,000Source | 13,957,000Source | 60,008,000Source | 13,580,000Source | 13,701,000Source | 46,312,000Source | 13,528,000Source | 19,524,000Source | 47,502,000Source | 13,653,000Source | 20,519,000Source | 46,365,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 22,753,000Source | 20,028,000Source | 16,317,000Source | 58,754,000Source | 26,308,000Source | 58,723,000Source | 34,830,000Source | 36,758,000Source | 30,968,000Source | 18,378,000Source | 27,873,000Source | 43,296,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 37,538,000Source | 24,481,000Source | 43,407,000Source | 28,172,000Source | 27,723,000Source | 39,602,000Source | 22,128,000Source | 23,550,000Source | 39,958,000Source | 21,591,000Source | 21,005,000Source | 10,877,000Source |
| Assets, CurrentUSD | 122,482,000Source | 171,760,000Source | 121,010,000Source | 156,480,000Source | 182,912,000Source | 124,145,000Source | 152,312,000Source | 194,008,000Source | 126,192,000Source | 160,742,000Source | 206,261,000Source | 218,126,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 8,763,000Source | 9,563,000Source | 54,586,000Source | 13,324,000Source | 11,180,000Source | 25,490,000Source | 9,320,000Source | 18,183,000Source | 24,739,000Source | 10,747,000Source | 17,971,000Source | 12,086,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,274,000Source | 22,813,000Source | 3,940,000Source | 8,453,000Source | 21,123,000Source | 4,195,000Source | 8,650,000Source | 24,576,000Source | 3,107,000Source | 8,876,000Source | 23,484,000Source | 17,692,000Source |
| Other Assets, NoncurrentUSD | 8,575,000Source | 913,000Source | 90,000Source | 1,458,000Source | 928,000Source | 24,290,000Source | 1,454,000Source | 1,439,000Source | 24,017,000Source | 1,436,000Source | 1,402,000Source | 970,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 52,078,000Source | 49,446,000Source | 53,380,000Source | 34,819,000Source | 50,945,000Source | 41,887,000Source | 30,818,000Source | 46,183,000Source | 46,400,000Source | 34,737,000Source | 60,638,000Source | 50,536,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source | 7,000Source |
| Additional Paid in CapitalUSD | 419,711,000Source | 406,424,000Source | 433,224,000Source | 411,259,000Source | 401,753,000Source | 429,121,000Source | 407,047,000Source | 397,477,000Source | 424,616,000Source | 407,076,000Source | 390,083,000Source | 375,873,000Source |
| Retained Earnings (Accumulated Deficit)USD | -136,718,000Source | -177,105,000Source | -153,913,000Source | -194,134,000Source | -175,151,000Source | -143,397,000Source | -190,391,000Source | -163,988,000Source | -145,551,000Source | -186,898,000Source | -159,754,000Source | -103,678,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 0Source | 4,173,000Source | 0Source | 5,968,000Source | 2,777,000Source | 0Source | 3,069,000Source | 3,113,000Source | 0Source | 1,753,000Source | 3,964,000Source | 2,287,000Source |
| Stockholders' Equity Attributable to ParentUSD | 283,000,000Source | 233,499,000Source | 279,318,000Source | 223,100,000Source | 229,386,000Source | 285,731,000Source | 219,732,000Source | 236,609,000Source | 279,072,000Source | 221,938,000Source | 234,300,000Source | 274,489,000Source |
| Liabilities and EquityUSD | 335,078,000Source | 282,945,000Source | 332,698,000Source | 257,919,000Source | 280,331,000Source | 327,618,000Source | 250,550,000Source | 282,792,000Source | 325,472,000Source | 256,675,000Source | 294,938,000Source | 325,025,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 27,874,000Source | 27,181,000Source | 45,779,000Source | 26,312,000Source | 30,286,000Source | 20,942,000Source | 21,881,000Source | 23,245,000Source | 19,794,000Source | 22,726,000Source | 35,491,000Source | 26,607,000Source |
| Operating Lease, Liability, CurrentUSD | 654,000Source | 4,472,000Source | 1,054,000Source | 3,521,000Source | 4,145,000Source | 987,000Source | 3,362,000Source | 4,428,000Source | 652,000Source | 3,304,000Source | 4,787,000Source | 3,362,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,817,000Source | 19,271,000Source | 3,201,000Source | 5,318,000Source | 17,864,000Source | 3,481,000Source | 5,706,000Source | 21,101,000Source | 2,655,000Source | 6,018,000Source | 19,738,000Source | 14,970,000Source |
| Deferred Income Tax Liabilities, NetUSD | 181,000Source | 302,000Source | 271,000Source | 210,000Source | 402,000Source | 271,000Source | 175,000Source | 357,000Source | 348,000Source | 185,000Source | 451,000Source | 1,876,000Source |
| Other Liabilities, NoncurrentUSD | 18,260,000Source | — | 4,129,000Source | — | — | 17,122,000Source | — | — | 22,073,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 348,000Source | 185,000Source | 451,000Source | 1,876,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 3,060,000Source | 1,697,000Source | 8,185,000Source | 5,962,000Source | 7,111,000Source | 5,725,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 5,035,000Source | 4,217,000Source | 17,832,000Source | 19,893,000Source | 12,501,000Source | 8,277,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -149,000Source | 520,000Source | 12,034,000Source | 998,000Source | 10,254,000Source | 5,347,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -77,000Source | -17,000Source | 432,000Source | -255,000Source | -1,466,000Source | -772,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 3,885,000Source | -246,000Source | -48,914,000Source | -2,519,000Source | -32,349,000Source | -37,130,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 66,535,000Source | 2,230,000Source | 0Source | 48,101,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 24,729,000Source | 20,407,000Source | 69,750,000Source | -1,016,000Source | 17,089,000Source | 79,340,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 5,179,000Source | 2,614,000Source | 9,595,000Source | 30,875,000Source | 2,109,000Source | 730,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 582,000Source | 4,306,000Source | 9,105,000Source | 5,683,000Source | 146,000Source | 1,171,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 244,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -859,000Source | -4,246,000Source | -8,912,000Source | -5,759,000Source | -76,000Source | -1,084,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 27,755,000Source | 16,041,000Source | 11,585,000Source | -9,374,000Source | -15,402,000Source | 41,198,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 23,016,000Source | 21,406,000Source | 16,581,000Source | 60,318,000Source | 58,987,000Source | 35,688,000Source | 31,232,000Source | 19,647,000Source | 29,021,000Source | 44,423,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 87,000Source | 0Source | 16,000Source | 0Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 0Source | 126,000Source | -339,000Source | -80,000Source | -66,000Source | 72,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 364,000Source | 275,000Source | 6,627,000Source | 356,000Source | 1,486,000Source | 408,000Source | 2,604,000Source | 2,986,000Source | 6,036,000Source | 4,895,000Source |
| DepreciationUSD | — | — | 1,081,000Source | 558,000Source | 1,888,000Source | 867,000Source | 1,574,000Source | 816,000Source | 4,296,000Source | 2,976,000Source | 1,075,000Source | 830,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | — | 798,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | — | — | — | — | -6,000Source | -6,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | -344,000Source | 0Source | 56,996,000Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | -5,195,000Source | 0Source | — | — | — | — | -5,195,000Source | 0Source | 8,000Source | -2,162,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | -2,073,000Source | — | -48,000Source | -68,000Source |
| General and Administrative ExpenseUSD | — | — | 16,301,000Source | 13,869,000Source | — | 20,142,000Source | — | 17,314,000Source | — | 81,711,000Source | 95,174,000Source | 62,510,000Source |
| GoodwillUSD | — | — | 84,607,000Source | 42,952,000Source | 106,946,000Source | 44,251,000Source | 88,589,000Source | 42,038,000Source | 88,210,000Source | 41,050,000Source | 40,373,000Source | 39,445,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | 0Source | — | 0Source | — | — | — | 5,759,000Source | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 5,759,000Source | 20,753,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -9,657,000Source | -5,627,000Source | -10,516,000Source | -3,409,000Source | 2,402,000Source | -1,612,000Source | -20,066,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 67,073,000Source | 3,673,000Source | 0Source | -334,000Source | -248,000Source | -1,881,000Source | 61,413,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | -255,000Source | -1,466,000Source | -772,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 57,416,000Source | -1,954,000Source | -10,516,000Source | -3,743,000Source | 2,154,000Source | -3,493,000Source | 41,347,000Source | -27,307,000Source | -56,076,000Source | -27,260,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -1,954,000Source | — | — | — | — | — | — | — | -27,260,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,035,000Source | 1,465,000Source | -5,108,000Source | 1,232,000Source | 5,376,000Source | 4,073,000Source | 2,287,000Source | 6,364,000Source | 10,575,000Source | 25,497,000Source |
| Operating ExpensesUSD | — | — | — | — | 20,623,000Source | 13,648,000Source | 17,091,000Source | 12,738,000Source | 63,479,000Source | — | -33,226,000Source | -36,570,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 10,575,000Source | 25,497,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 52,000Source | 60,000Source | 193,000Source | 168,000Source | 70,000Source | 87,000Source |
| Restructuring CostsUSD | — | — | — | 483,000Source | — | — | — | 62,000Source | — | 1,441,000Source | — | — |
| Share-based Payment Arrangement, Expense | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 49,298,000Source | 36,062,000Source | 72,506,000Source | 45,108,000Source | 67,384,000Source | 35,948,000Source | 197,141,000Source | 248,693,000Source | 225,180,000Source | 146,120,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | — | — | 13,996,000Source | 13,292,000Source | 15,605,000Source | 12,330,000Source | 60,875,000Source | — | — | — |
| Operating Income (Loss)USD | — | — | -5,622,000Source | -7,092,000Source | -5,408,000Source | -4,641,000Source | -2,974,000Source | -5,685,000Source | -22,353,000Source | -33,926,000Source | -68,117,000Source | -53,529,000Source |
| Other Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | 10,575,000Source | 25,497,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -9,657,000Source | -5,627,000Source | -10,516,000Source | -3,409,000Source | 2,402,000Source | -1,612,000Source | -20,066,000Source | -27,562,000Source | -57,542,000Source | -28,032,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | -255,000Source | -1,466,000Source | -772,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 57,416,000Source | -1,954,000Source | -10,516,000Source | -3,743,000Source | 2,154,000Source | -3,493,000Source | 41,347,000Source | -27,307,000Source | -56,076,000Source | -27,260,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.7Source | -0.03Source | -0.12Source | -0.05Source | 0.03Source | -0.04Source | 0.5Source | -0.35Source | -0.76Source | -0.38Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.7Source | -0.03Source | -0.12Source | -0.05Source | 0.03Source | -0.04Source | 0.5Source | -0.35Source | -0.76Source | -0.38Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 82,454,657Source | 78,044,254Source | 86,213,930Source | 81,297,402Source | 85,322,941Source | 79,891,829Source | 82,092,345Source | 77,499,423Source | 73,524,476Source | 71,238,103Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 82,454,657Source | 78,044,254Source | 86,213,930Source | 81,297,402Source | 90,168,853Source | 79,891,829Source | 82,092,345Source | 77,499,423Source | 73,524,476Source | 71,238,103Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 364,000Source | 275,000Source | 6,627,000Source | 356,000Source | 1,486,000Source | 408,000Source | 2,604,000Source | 2,986,000Source | 6,036,000Source | 4,895,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | — | 85,000Source | — | — | — | — | — | 241,000Source | — | — |
| Costs and ExpensesUSD | — | — | 54,920,000Source | 43,154,000Source | — | 75,755,000Source | — | 61,889,000Source | — | 282,619,000Source | 293,297,000Source | 199,649,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | — | — | — | — | — | 798,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 16,301,000Source | 13,869,000Source | — | 20,142,000Source | — | 17,314,000Source | — | 81,711,000Source | 95,174,000Source | 62,510,000Source |
| Gross ProfitUSD | — | — | — | — | 15,215,000Source | 9,007,000Source | 14,117,000Source | 7,053,000Source | 41,126,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -9,657,000Source | -5,627,000Source | -10,516,000Source | -3,409,000Source | 2,402,000Source | -1,612,000Source | -20,066,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -20,066,000Source | -14,859,000Source | -26,676,000Source | -21,563,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.12Source | -0.07Source | -0.12Source | -0.04Source | 0.03Source | -0.02Source | -0.24Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.12Source | -0.07Source | -0.12Source | -0.04Source | 0.03Source | -0.02Source | -0.24Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 67,073,000Source | 3,673,000Source | 0Source | -334,000Source | -248,000Source | -1,881,000Source | 61,413,000Source | — | — | — |
| Interest Income (Expense), NetUSD | — | — | — | 1,764,000Source | — | 1,155,000Source | — | 1,321,000Source | — | 7,214,000Source | 8,442,000Source | 3,434,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 1,127,000Source | 1,764,000Source | 331,000Source | 1,155,000Source | 473,000Source | 1,321,000Source | 4,241,000Source | 7,214,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -1,954,000Source | — | — | — | — | — | — | — | -27,260,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,035,000Source | 1,465,000Source | -5,108,000Source | 1,232,000Source | 5,376,000Source | 4,073,000Source | 2,287,000Source | 6,364,000Source | 10,575,000Source | 25,497,000Source |
| Operating ExpensesUSD | — | — | — | — | 20,623,000Source | 13,648,000Source | 17,091,000Source | 12,738,000Source | 63,479,000Source | — | -33,226,000Source | -36,570,000Source |
| Restructuring CostsUSD | — | — | — | 483,000Source | — | — | — | 62,000Source | — | 1,441,000Source | — | — |
| Selling and Marketing ExpenseUSD | — | — | 482,000Source | 314,000Source | — | 1,634,000Source | — | 1,435,000Source | — | 7,950,000Source | 10,438,000Source | 7,749,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | — | — | — | 0Source | — | — | — | — | — | — | — | 0Source |
Filing attachments
ex99-1.htm · SCHEDULE 13D · 2026-10-15
Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.0001 per share, of Strata Critical Medical, Inc., and that this agreement be included as an Exh…
Read attachment ↗tm2619991d2_ex99-1.htm · SCHEDULE 13G/A · 2026-07-08
EXHIBIT 1 WHEREAS, in accordance with Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934 (the "Act"), only one joint Statement and any amendments thereto need to be filed whenever one or more persons are required to file such a Statement or any amendments thereto pursuant to Section 13(d) of the Act with respect to the same securities, provided that said persons agree in writing that such Statement or amendments thereto is filed on behalf of each of them; NOW, THEREFORE, the partie…
Read attachment ↗ex991-exhibita.htm · SCHEDULE 13G · 2026-06-17
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Strata Critical Medical, Inc. dated as of June 17, 2026 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(2) under the Securities Exchange Act of 1934, as amended. Dated: June 17, 2026 Northern Right Capital Management, …
Read attachment ↗srta-ex41xq42025.htm · 10-K · 2026-03-03
Exhibit 4.1 NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [●] STRATA CRITICAL MEDICAL, INC. INCORP…
Read attachment ↗srta-ex44xq42025.htm · 10-K · 2026-03-03
Exhibit 4.4 Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 As used herein, references to “we,” “our,” “us” or “Strata” are to Strata Critical Medical, Inc. Terms used, but not defined, herein have the meanings given to such terms in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Form 10-K”). Unless otherwise indicated or the context requires otherwise, all references herein to “warrants” include our Public Wa…
Read attachment ↗tm265039d1_ex99-1.htm · 8-K · 2026-02-05
Exhibit 99.1 Strata Announces Closing of Revolving Credit Facility to Support Acquisition Strategy Execution $30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and remain unencumbered New York, Feb 5, 2026 -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ …
Read attachment ↗